These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1534637)

  • 1. [Hepatitis B markers at an institution for mentally retarded].
    Svendsen IB
    Ugeskr Laeger; 1992 Apr; 154(18):1287-8. PubMed ID: 1534637
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occurrence of hepatitis B and C among mentally retarded].
    Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS
    Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hepatitis B in a ward for mentally retarded HBsAg carriers.
    Eskola J; Keski-Oja J; Wilska M; Autio S
    Infection; 1986; 14(4):170-2. PubMed ID: 2944844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of serologic markers of hepatitis B in a New Brunswick institution for the mentally retarded.
    Farley JD; Balram BC; Margison D; Chaudhary RK
    CMAJ; 1987 Jul; 137(1):47-8. PubMed ID: 2954630
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of serological markers to hepatitis B in mentally retarded persons in an institution].
    Dyrborg J; Jacobsen P; Jarbøl H; Søndergaard M; Lauritsen A; Lee K
    Ugeskr Laeger; 1988 Mar; 150(12):727-9. PubMed ID: 3363691
    [No Abstract]   [Full Text] [Related]  

  • 8. [e-Antigens in patients with chronic hemodialysis].
    Gmelin K; Thamer G; Tschöpe W; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():581-2. PubMed ID: 612039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Distribution of serologic markers of hepatitis B in a sample of the population of Cremona province].
    Romanini G; Bodini U; Pennacchio A; Cavalli P; Carpanelli R; Pecoroni L; Sampaoli G; Bini MG; D'Avossa A; Frosi A
    Riv Emoter Immunoematol; 1984; 31(2):165-73. PubMed ID: 6536097
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serological markers for hepatitis B virus and delta antibody in Brazilian male homosexuals].
    Ferraz ML; Vilela MP; Silva AE; Paiva ER
    Rev Paul Med; 1985; 103(5):228-30. PubMed ID: 3832313
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on Australia antigen (HB-Ag) in a psychiatric community].
    Boll Soc Ital Biol Sper; 1977 Sep; 53(18):1495-8. PubMed ID: 146506
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetic findings correlated with immune response to hepatitis virus B of institutionalized Down syndrome individuals.
    Smith A; Boughton CR; Hawkes RA; Schroeter DR
    Am J Ment Defic; 1982 Sep; 87(2):223-6. PubMed ID: 6214954
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis-B surface antigen among residents of an institution for the mentally retarded.
    Bruhl HH; Bauer H; Levy BS; Siem RA
    Minn Med; 1976 Apr; 59(4):263-7. PubMed ID: 131906
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 16. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevalence of markers to hepatitis B virus in dentists in eastern Lombardy].
    Ribero ML; Bollani A; Donato F; Tagger A; Salvato A; Nardi G
    Riv Ital Stomatol; 1984 Sep; 53(9):593-601. PubMed ID: 6598901
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 19. [A differentiated policy of vaccination against hepatitis B in an institute for the mentally retarded].
    Wagemans A; Zielhuis GA
    Ned Tijdschr Geneeskd; 1985 Jul; 129(28):1325-8. PubMed ID: 2931608
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of hepatitis B infection in institutions for the mentally retarded. Epidemiologic characteristics in the province of Vizcaya].
    Aristegui Fernández J; Cisterna Cáncer R; Muñiz Saitua J; Gorostiza E; Pérez Legorburu A; Cos Arregui B; Delgado Rubio A
    Med Clin (Barc); 1989 Mar; 92(9):323-7. PubMed ID: 2716426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.